NasdaqCM - Delayed Quote USD

SAB Biotherapeutics, Inc. (SABSW)

Compare
0.0368
+0.0048
+(15.00%)
At close: January 31 at 4:00:00 PM EST

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -10.35M
Q4'23
Q1'24
Q2'24
Q3'24
-20M
-15M
-10M
-5M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5455
Avg. Estimate 120k250k1.32M800k
Low Estimate ----1.2M--
High Estimate 500k500k1.7M2M
Year Ago Sales 305.01k944.58k2.24M1.32M
Sales Growth (year/est) -60.66%-73.53%-40.90%-39.54%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SABSW --------
S&P 500 9.91%10.33%14.01%13.75%

Related Tickers